Apt time to buy some of the pharma stocks: Manish Sonthalia
In a rising interest rate scenario, all these things are bound to happen. We are coming out of a regime where there was zero cost of capital two years ago. And today, cost of capital is significantly higher than those levels. So, if your denominator is expanded, your valuations will obviously cut.
